首页 > 市场调查报告书 > 製药

个人化医学

市场调查报告书

商品编码

1424175

精准诊断与检测技术进步

Technology Advancements in Precision Diagnostics and Testing

出版日期: 2023年12月21日 | 出版商:

Frost & Sullivan | 英文 78 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

创新正在推动价值医学时代的到来，并实现预防性和个人化医学。

精确的诊断在当今的医疗保健中至关重要，可以根据遗传、分子和环境因素为个别患者量身定制治疗方案。这种有针对性的方法提高了准确性，实现了早期检测和有针对性的治疗，最大限度地减少了试验错治疗，并优化了治疗结果。

透过利用先进技术和个人化资料，精准诊断使医疗保健专业人员能够做出明智的决策，改善患者照护，并提供更有效和高效的医疗保健。促进护理服务。

尖端的精准诊断技术正在改变医学和患者照护的模式。这些先进技术细緻地分析血液、组织和遗传物质等生物样本，以准确诊断各种疾病和病症。精准诊断技术在医疗保健中的重要性在于其能够准确识别疾病、减少误诊、防止不必要的治疗、提高标靶治疗的有效性。最终，这有助于改善患者的治疗效果。

基因组定序、突变组学以及人工智慧和巨量资料整合的技术进步正在推动该领域的成长。

Frost & Sullivan 的这项研究服务专注于识别各种能够实现精准诊断的新兴技术、研究各种技术的关键参与者以及精准诊断在各种疾病领域的适用性。

Frost & Sullivan 确定了精准诊断领域的三个成长机会，这些机会有可能改变市场。

主要问题

1.精准诊断和测试开发的驱动因素和挑战是什么？

2. 精准诊断将如何改变各疾病领域的诊断？

3. 粒线体疗法的资金筹措和合作方案是什么？

4. 精准诊断和检测领域的主要创新者有哪些？

5.该领域的研究和发展趋势是什么？

6.主要的成长机会是什么？

介绍
促进因素
促进因素分析
成长抑制因素
成长抑制因素分析
范围和细分
精确诊断的效用
液体活体组织切片精准诊断
预测性基因检测作为详细检查的有效手段
药物基因体学在精准诊断的应用
PCR技术的进步
新技术强化精密检测
实现详细检查/诊断的新技术

精准诊断：应用于多种疾病

详细检查在癌症领域的作用
实现肿瘤学详细检查/诊断的技术
实现精准医疗的新型生物标记
实现精准医疗的微流控设备
创新聚焦－癌症领域精准侦测技术
最近的伴随诊断核准- 癌症治疗选择
感染疾病－需要详细检查
透过详细测试实现感染疾病监测和管理
感染疾病详细检查新技术
可对感染疾病进行详细检查/诊断的分子诊断剂
多重分子 POC 测试可实现精准医疗
创新聚焦－感染疾病精准检测技术
神经系统疾病 - 诊断挑战
精密测试如何克服当前的诊断挑战
基于血液的生物标记可改善神经退化性疾病评估
能够对神经系统疾病进行详细检查/诊断的技术
创新聚焦－神经系统疾病详细检查技术
CVD-当前检查问题和未来方向
可对 CVD 进行详细检查/诊断的分子诊断
创新聚焦－神经系统疾病详细检查技术
遗传/罕见疾病 - 诊断挑战
精确的测试方法可克服遗传/罕见疾病的诊断挑战
可对遗传/罕见疾病进行详细检查/诊断的技术

实现精确诊断的因素

实现精准诊断
精密检测中的人工智慧和机器学习
应用
巨量资料分析细化检验

研发重点

加强细节检查的策略性问题

市场动态

公共和私人资金推动精确测试开发
与精准诊断公司合作

成长机会宇宙

成长机会 1：扩大基因组筛检的采用
成长机会2：加强巨量资料和人工智慧
成长机会3：新生物标记的发现

下一步

下一步
为什么是霜冻，为什么是现在？
免责声明

简介目录

Product Code: DACA

Innovation is driving the era of value-based care and enabling preventive and personalized health.

Precision diagnosis in today's healthcare is pivotal, tailoring treatment to individual patients based on genetic, molecular, and environmental factors. This targeted approach enhances accuracy, enables early detection and targeted treatment, minimizes trial-and-error treatment, and optimizes therapeutic outcomes.

By leveraging advanced technologies and personalized data, precision diagnosis empowers healthcare professionals to make informed decisions, improving patient care and fostering more effective and efficient healthcare delivery.

Cutting-edge precision diagnostic technologies are transforming the medical science and patient care landscape. These advanced methods meticulously analyze biological samples, such as blood, tissue, and genetic material, to accurately diagnose a range of diseases and conditions. The importance of precision diagnostic technology in healthcare lies in its ability to precisely identify diseases, reduce misdiagnoses, prevent unnecessary treatment, and enhance the effectiveness of targeted therapies. Ultimately, this contributes to improved patient outcomes.

Technology advancements around genomic sequencing, muti-omics, and AI and Big Data integration have boosted this space's growth.

This Frost & Sullivan research service focuses on identifying different emerging technologies that enable precision diagnosis, key participants working on different technologies, and the applicability of precision diagnosis across different disease areas.

Frost & Sullivan identifies 3 growth opportunities for precision diagnosis that could potentially transform the market.

Key Questions Answered

1. What are the drivers and challenges for precision diagnostics and testing development?

2. How can precision diagnosis transform diagnosis across different disease areas?

3. What does the mitochondrial therapeutics funding and partnership scenario look like?

4. Who are the main precision diagnostics and testing innovators?

5. What are the R&D trends in this space?

6. What are the key growth opportunities?

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Precision Diagnostics and Testing
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Growth Opportunity Analysis

Introduction
Growth Drivers
Growth Driver Analysis
Growth Restraints
Growth Restraint Analysis
Scope and Segmentation
Utility of Precision Diagnostics
Liquid Biopsy in Precision Diagnosis
Predictive Genetic Testing as an Effective Tool for Precision Testing
Pharmacogenomics in Precision Diagnosis
Technological Advancements in PCR)
Emerging Technologies Bolstering Precision Testing
Emerging Technologies Enabling Precision Testing/Diagnosis

Precision Diagnostics: Application across Different Diseases

The Role of Precision Testing in Oncology
Technologies Enabling Precision Testing/Diagnosis for Oncology
Novel Biomarkers Enabling Precision Medicine
Microfluidic Devices Enabling Precision Medicine
Innovation Spotlight-Precision Testing Technology for Oncology
Recent CDx Approvals-Cancer Therapy Selection
Infectious Diseases-The Need for Precision Testing
Precision Testing Enables Infectious Disease Surveillance and Management
Emerging Technologies for the Precision Testing of Infectious Diseases
Molecular Diagnostics Enabling Precision Testing/Diagnosis for Infectious Diseases
Multiplex Molecular POC Testing Enabling Precision Medicine
Innovation Spotlight-Precision Testing Technology for Infectious Diseases
Neurological Diseases-Challenges with Diagnostics
How Precision Testing Helps Overcome Current Diagnostic Challenges
Blood-based Biomarkers to Improve Neurodegenerative Disease Assessment
Technologies Enabling Precision Testing/Diagnosis for Neurological Diseases
Innovation Spotlight-Precision Testing Technology for Neurological Diseases
CVDs-Current Testing Challenges and the Way Forward
Molecular Diagnostics Enabling Precision Testing/Diagnosis for CVDs
Innovation Spotlight-Precision Testing Technology for Neurological Diseases
Genetic/Rare Diseases-Challenges With Diagnosis
How Precision Testing Helps Overcome Current Diagnostic Challenges in Genetic/Rare Diseases
Technologies Enabling Precision Testing/Diagnosis for Genetic/Rare Diseases